Pushing Fluids: A Case for Liquid Biomarkers Before Imaging in Pre-Prostate Biopsy Decision-making

Helen Y Hougen; Ali Merhe; Sanoj Punnen

doi:10.1016/j.euf.2022.05.007

Pushing Fluids: A Case for Liquid Biomarkers Before Imaging in Pre-Prostate Biopsy Decision-making

Eur Urol Focus. 2022 Jul;8(4):893-894. doi: 10.1016/j.euf.2022.05.007. Epub 2022 Jun 9.

Authors

Helen Y Hougen¹, Ali Merhe², Sanoj Punnen³

Affiliations

¹ Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: [email protected].
² Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
³ Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

PMID: 35691842
DOI: 10.1016/j.euf.2022.05.007

Abstract

For patients with clinical suspicion of prostate cancer, liquid biomarkers are the next best test because of their accessibility, objectiveness, and noninvasive nature. A highly sensitive cutoff for these biomarkers should be used to triage patients before use of magnetic resonance imaging.

MeSH terms

Humans
Image-Guided Biopsy / methods
Magnetic Resonance Imaging / methods
Male
Prostate* / diagnostic imaging
Prostate* / pathology
Prostate-Specific Antigen
Prostatic Neoplasms* / diagnostic imaging
Prostatic Neoplasms* / pathology

Substances

Prostate-Specific Antigen